Skip to Content

WPI 2227 (Flutamide 125 mg)

Pill with imprint WPI 2227 is Brown & White, Capsule-shape and has been identified as Flutamide 125 mg. It is supplied by Watson Pharmaceuticals, Inc..

Flutamide is used in the treatment of hirsutism; prostate cancer and belongs to the drug classes antiandrogens, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Flutamide 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2227

Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227
Flutamide 125 mg WPI 2227

Flutamide

Imprint:
WPI 2227
Strength:
125 mg
Color:
Brown & White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiandrogens
Hormones/antineoplastics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals, Inc.
National Drug Code (NDC):
00591-2466

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide